Body Composition, Frailty, and Function in Rehabilitation

Launched by CHANGI GENERAL HOSPITAL · Jul 28, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how body composition—specifically muscle mass, body fat, and a measure called phase angle—can help predict how well patients will recover during their rehabilitation after being hospitalized. The investigators want to find out if these body measurements, along with factors like age and frailty, can give insights into a patient's recovery progress. Patients who are in the hospital for rehabilitation after a stroke, illness, or surgery may be eligible to participate.

If you or a loved one qualifies for this study, you will have your body composition measured using a special device called a body composition monitor. During your rehabilitation, healthcare providers will track your strength and speed using various tools. This information will help researchers understand the relationship between body composition and recovery outcomes. To participate, you need to be medically stable and able to understand the consent form, either by yourself or with help from a family member. It's a great opportunity to contribute to research that could improve rehabilitation for future patients!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Transferred under the Rehabilitation Medicine service for post-acute rehabilitation
• 2. Rehabilitation diagnosis of:
• • 1. Stroke with motor weakness (modified Rankin scale 1-5), or
• • 2. Deconditioning (from sepsis, post-ICU admission, heart failure, falls, musculoskeletal conditions with or without pain, or other conditions), or
• • 3. Pulmonary rehabilitation (with or with long-term oxygen therapy), or
• • 4. Lower limb amputees (transtibial or transfemoral)
• • 3. Medically stable
• • 4. Able to understand English consent form or suitably-translated document, or have a family member/legally-authorised representative who is able to do so and willing to provide consent
• Exclusion Criteria:
• • 1. Pacemaker or implantable defibrillator in-situ
• • 2. Medical devices or surgical implants that will interfere with BIA measurement per the manufacturer's guidelines
• • 3. Abnormal fluid status (overloaded or depleted) at the point of screening
• • 4. Cognitive or physical inability to tolerate sitting/lying still for 2mins (for BIA measurement)